PAB12535

antibody from Abnova Corporation

Targeting: NR1H3 LXR-a, LXRa, RLD-1

Western blot (Supportive data in Antibodypedia)

Antibody Data

Product number

PAB12535

Provider

Abnova Corporation

Proper citation

Abnova Corporation Cat#PAB12535, RRID:AB_10553986

Product name

NR1H3/NR1H2 polyclonal antibody

Antibody type

Polyclonal

Antigen

A synthetic peptide corresponding to amino acids 50-150 of human NR1H3/NR1H2.

Reactivity

Human

Host

Rabbit

Vial size

100 uL

Storage

Store at 4°C. Do not freeze.

References

Submitted references

Suppression of 2,3-oxidosqualene cyclase by high fat diet contributes to liver X receptor-alpha-mediated improvement of hepatic lipid profile.

Dang H, Liu Y, Pang W, Li C, Wang N, Shyy JY, Zhu Y
The Journal of biological chemistry 2009 Mar 6;284(10):6218-26

---

Atorvastatin decreases lipoprotein lipase and endothelial lipase expression in human THP-1 macrophages.

Qiu G, Hill JS
Journal of lipid research 2007 Oct;48(10):2112-22

---

NO-1886 upregulates ATP binding cassette transporter A1 and inhibits diet-induced atherosclerosis in Chinese Bama minipigs.

Zhang C, Yin W, Liao D, Huang L, Tang C, Tsutsumi K, Wang Z, Liu Y, Li Q, Hou H, Cai M, Xiao J
Journal of lipid research 2006 Sep;47(9):2055-63

Western blot

Supportive validation

Submitted by

Abnova Corporation (provider)

Main image

Experimental details

Western blot analysis of LXR in human liver using NR1H3/NR1H2 polyclonal antibody (Cat # PAB12535).

Supportive validation

Submitted by

Abnova Corporation (provider)

Main image

Experimental details

Western blot analysis of LXR in lysates of cells that were transfected with the pCMV6-ENTRY control or pCMV6-ENTRY NR1H3 cDNA using NR1H3/NR1H2 polyclonal antibody (Cat # PAB12535).